| H2012 | Behavioral health day treatment, per hour | 12 | 50 | 8,810 | $110 | $2.2M |
| 96361 | The provider administers intravenous, or IV, fluids with electrolytes through an already established intravenous route for each additional hour to treat more severe dehydration. | 22 | 140 | 3,200 | $160 | $1.1M |
| 99283 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a low level of medical decision making. | 34 | 360 | 1,550 | $70 | $614.4K |
| 99284 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making. | 45 | 430 | 760 | $60 | $484.6K |
| 99282 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a straightforward level of medical decision making. | 47 | 190 | 1,790 | $90 | $390.9K |
| 41899 | Use this code to report a procedure on the teeth and adjoining alveolar structures for which there is no specific code available. | 34 | 40 | 150 | $530 | $381.9K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 39 | 140 | 2,200 | $90 | $358.4K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 9 | 10 | 40 | $570 | $357.5K |
| 99285 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a high level of medical decision making. | 37 | 330 | 1,350 | $60 | $338K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 53 | 170 | 720 | $70 | $272.7K |